tirzepatide and pancreatitis Experimental design timeline for L‐arginine‐induced Understanding Pancreatitis Risk with Mounjaro

The full results from Lillys ATTAIN-1 trial were published in the NEJM this week, evaluating orforglipron for obesity treatment

Childhood trauma disrupts IGF-1, sleep, stress hormones, insulin, leptin, and ghrelin

Stop taking Biotin-containing supplements at least 48 to 72 hours before your test (see our FAQs)

Many patients consider combining them hoping to amplify results, but this strategy carries significant cardiovascular and metabolic risks that most prescribers advise against

Results Between 73.2% (SUSTAIN 6) and 89.6% (STEP 2) of participants in the four studies were taking metformin

[1] [2] Long-term cardiovascular outcomes and the full safety profile of this mechanism in humans remain to be established in ongoing Phase 3 trials